Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection

被引：0
|
作者：
Hyungjin Kim
Kum Ju Chae
Soon Ho Yoon
Miso Kim
Bhumsuk Keam
Tae Min Kim
Dong-Wan Kim
Jin Mo Goo
Chang Min Park
机构：
[1] Seoul National University Medical Research Centre,Department of Radiology, Seoul National University College of Medicine, and Institute of Radiation Medicine
[2] Chonbuk National University Medical School and Hospital,Department of Radiology, Institute of Medical Science, and Research Institute of Clinical Medicine
[3] Seoul National University Cancer Research Institute,Department of Internal Medicine
[4] Seoul National University Hospital,undefined
来源：
European Radiology | 2018年 / 28卷
关键词：
Non-small-cell lung carcinoma; Epidermal growth factor receptor; Protein kinase inhibitor; Drug resistance; Image-guided biopsy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：861 / 868
页数：7
相关论文
共 50 条
  • [21] The EGFR T790M Mutation in Acquired Resistance to an Irreversible Second-Generation EGFR Inhibitor
    Kim, Youngwook
    Ko, Jeonghun
    Cui, Zhengyun
    Abolhoda, Amir
    Lee, Jeeyun
    Ahn, Jinseok
    Ou, Sai-Hong
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S421 - S421
  • [22] Detection of T790M mutation in EGFR gene, an EGFR-TKI resistant mutation, in tumor samples unexposed to EGFR TKIs
    Koba, Hayato
    Kimura, Hideharu
    Nishikawa, Shingo
    Yoneda, Taro
    Sone, Takashi
    Kasahara, Kazuo
    CANCER RESEARCH, 2016, 76
  • [23] EGFR T790M detection and osimertinib treatment response evaluation by liquid biopsy in lung adenocarcinoma patients with acquired resistance to first generation EGFR tyrosine kinase inhibitors
    Chenguang Li
    Rui Jia
    Hailin Liu
    Bin Zhang
    Changli Wang
    Diagnostic Pathology, 13
  • [24] EGFR T790M detection and osimertinib treatment response evaluation by liquid biopsy in lung adenocarcinoma patients with acquired resistance to first generation EGFR tyrosine kinase inhibitors
    Li, Chenguang
    Jia, Rui
    Liu, Hailin
    Zhang, Bin
    Wang, Changli
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [25] Correlation and Problems of Re-Biopsy and Liquid Biopsy for Detecting T790M Mutation
    Komiya, K.
    Nakamura, T.
    Hayase, M.
    Hirakawa, H.
    Ogusu, S.
    Abe, T.
    Nakashima, C.
    Takahashi, K.
    Takeda, Y.
    Kimura, S.
    Sueoka-Aragane, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2130 - S2131
  • [26] Detection of T790M gefitinib resistance mutation in EGFR using the BEAMing method
    Taniguchi, Kazuya
    Nishitani, Kimiyoshi
    Okami, Jiro
    Kodama, Ken
    Higashiyama, Masahiko
    Kato, Kikuya
    CANCER RESEARCH, 2010, 70
  • [27] Plasma EGFR liquid biopsy test in the assessment of exon 20 T790M mutation in lung cancer patients
    Lantos, A.
    Toth, E.
    VIRCHOWS ARCHIV, 2018, 473 : S310 - S311
  • [28] Should We Perform Repeated Re-biopsy for the Detection of T790M Mutation?
    Kim, Saerom
    Kim, Soo Han
    Kim, Jinmi
    Kim, Mi-Hyun
    Lee, Min Ki
    Eom, Jung Seop
    CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1190 - 1197
  • [29] Selection for the EGFR T790M gatekeeper resistance mutation may vary among different small molecule EGFR TKIs
    Chmielecki, Juliann
    Pietanza, Maria C.
    Kris, Mark
    Miller, Vincent
    Stout, Thomas
    Pao, William
    CANCER RESEARCH, 2010, 70
  • [30] Standardized uptake value on 18F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs
    Yoshida, Tatsuya
    Tanaka, Hirotaka
    Kuroda, Hiroaki
    Shimizu, Junichi
    Horio, Yoshitsugu
    Sakao, Yukinori
    Inaba, Yoshitaka
    Iwata, Hiroshi
    Hida, Toyoaki
    Yatabe, Yasushi
    LUNG CANCER, 2016, 100 : 14 - 19
12345